Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Rebif long-term data confirm dose-related efficacy; Ares-Serono to enhance labeling

March 3, 2000

Nonimmunosuppressive immunophilin-binding neurotrophic compounds designed at Pfizer

March 2, 2000

Elan's NDA for ziconotide accepted for filing

March 2, 2000

Acadia identifies novel mechanism of action for antipsychotics

March 2, 2000

NK1 receptor antagonist and prodrug thereof for treatment of emesis

March 1, 2000

Ono-2506 has protective and therapeutic efficacy in EAN

March 1, 2000

Rotamase inhibitors developed at Agouron for neurological disorders

March 1, 2000

5-HT2C receptor inverse agonists selected for further study in CNS disorders

Feb. 29, 2000

Bioprojet claims new, orally active histamine H3 antagonists

Feb. 29, 2000

Selective rotamase inhibitors described by Pfizer for neurological disorders

Feb. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...